New antibody combo offers hope for hard-to-treat multiple myeloma
Disease control
ENROLLING_BY_INVITATION
This study is for people with multiple myeloma that has returned or stopped responding to prior treatments. Researchers want to see if adding a new antibody drug called HuL001 to two standard medications (lenalidomide and dexamethasone) is safe and can shrink the cancer. About 21…
Phase: PHASE1, PHASE2 • Sponsor: HuniLife Biotechnology, Inc. • Aim: Disease control
Last updated May 17, 2026 11:53 UTC